{"title":"COVID‐19 and clozapine use in an early intervention for psychosis service","authors":"Rizwana Jafry, Marlene Kelbrick","doi":"10.1002/pnp.737","DOIUrl":null,"url":null,"abstract":"Clozapine prescribing in treatment‐refractory schizophrenia is underutilised, including in early intervention for psychosis services. COVID‐19 has brought various challenges to the utilisation of clozapine, particularly in the context of initiation and monitoring. There is a need for clear national guidance in this regard.","PeriodicalId":43913,"journal":{"name":"Progress in Neurology and Psychiatry","volume":null,"pages":null},"PeriodicalIF":1.3000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Neurology and Psychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/pnp.737","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NEUROSCIENCES","Score":null,"Total":0}
引用次数: 1
Abstract
Clozapine prescribing in treatment‐refractory schizophrenia is underutilised, including in early intervention for psychosis services. COVID‐19 has brought various challenges to the utilisation of clozapine, particularly in the context of initiation and monitoring. There is a need for clear national guidance in this regard.
期刊介绍：
Progress in Neurology and Psychiatry is published nine times a year, and is a journal for specialists in secondary care, GPs with an interest in neurology and psychiatry, community psychiatric nurses and other specialist healthcare professionals. Articles cover management, news updates and opinion in all areas of neurology and psychiatry.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
